Care Capital III LLC

USReporting entityDirector

Insider

Care Capital III LLC

USReporting entityDirector

Transactions

Issuers

Buys / Sells

4/0

Last tx

13 Feb 2018

Current positions

Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.

Issuer	Shares	Source	Last tx	Detail
Vaxart, Inc.	30,793,670	reported	13 Feb 2018	tx 1+30,793,670
CoLucid Pharmaceuticals, Inc.	5,954	reported	05 May 2015	tx 5+1,307,515

Recent transactions

Date	Type	Issuer	Qty	Price	Signals
13 Feb 2018	GRANT_AWARD	Vaxart, Inc.	30,793,670	—
12 Jan 2015	PURCHASE	CoLucid Pharmaceuticals, Inc.	959,872	0.00 USD	deriv
12 Jan 2015	PURCHASE	CoLucid Pharmaceuticals, Inc.	5,353	0.00 USD	deriv
05 May 2015	GRANT_AWARD	CoLucid Pharmaceuticals, Inc.	5,954	0.00 USD

InsiderLens aggregates public information issued by financial regulators (SEC, AMF, FCA, BaFin, AFM, FI, ASX). The service constitutes neither investment advice nor a recommendation to buy or sell. Past performance is no guarantee of future results. Investing in financial instruments carries the risk of capital loss.

Current positions

Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.

Issuer	Shares	Source	Last tx	Detail
Vaxart, Inc.	30,793,670	reported	13 Feb 2018	tx 1+30,793,670
CoLucid Pharmaceuticals, Inc.	5,954	reported	05 May 2015	tx 5+1,307,515

Recent transactions

Date	Type	Issuer	Qty	Price	Signals
13 Feb 2018	GRANT_AWARD	Vaxart, Inc.	30,793,670	—
12 Jan 2015	PURCHASE	CoLucid Pharmaceuticals, Inc.	959,872	0.00 USD	deriv
12 Jan 2015	PURCHASE	CoLucid Pharmaceuticals, Inc.	5,353	0.00 USD	deriv
05 May 2015	GRANT_AWARD	CoLucid Pharmaceuticals, Inc.	5,954	0.00 USD